Gana Misra
By Gana MisraCEO, Finrep
Mon Sep 21 2026

IPO Pricing Process: A 2026 Practitioner Walkthrough

Share
IPO Pricing Process: A 2026 Practitioner Walkthrough

IPO Pricing Process: A 2026 Practitioner Walkthrough

The IPO pricing process is the most consequential decision in the entire going-public journey. Get it wrong in one direction and the stock breaks issue price on day one, destroying investor confidence. Get it wrong in the other and you leave hundreds of millions of dollars on the table, transferred directly from your shareholders to the institutional investors your underwriter favours. This walkthrough explains exactly how the price is set, who controls each step, what the regulatory guardrails are, and where issuers most often get burned.

Key takeaway: The final IPO price is not set by a formula. It is negotiated, the night before trading begins, between the issuer's board and the lead underwriter, based on a live demand curve built during the roadshow. Understanding that process, and its built-in conflicts of interest, is what separates a well-priced IPO from an expensive lesson.

For the S-1 filing mechanics that precede pricing, see Form S-1 Filing: A Practitioner's 2026 Walkthrough. For the roadshow itself, see the IPO Roadshow Process: A 2026 Practitioner Walkthrough. This article focuses exclusively on the pricing mechanics.


How Is the IPO Price Actually Set?

The IPO price is set through a bookbuilding process in which the lead underwriter aggregates non-binding indications of interest (IOIs) from institutional investors during the roadshow, then negotiates a final price with the issuer the evening before trading begins.

That sentence contains more information than most existing coverage provides. Here is what it actually means in practice.

The process runs in four distinct phases:

  1. Pre-roadshow price range calibration (testing the waters, S-1/A filing)
  2. Bookbuilding during the roadshow (10-14 days of demand aggregation)
  3. The pricing meeting (the night before trading)
  4. Post-pricing stabilisation (greenshoe mechanics, Reg M constraints)

Each phase has specific regulatory requirements and specific pitfalls. Work through them in order.


Phase 1: Setting the Preliminary Price Range

Before the roadshow begins, the underwriter and issuer must file a preliminary prospectus (the "red herring" or S-1/A) that includes a bona fide price range. This range is not a guess. It reflects real pre-marketing intelligence.

How the range is calibrated

The underwriter's equity research analysts build a valuation using three primary methods:

  • Comparable company analysis: trading multiples of public peers (P/E, EV/Revenue, EV/EBITDA)
  • Precedent transaction analysis: M&A multiples from recent deals in the sector
  • DCF analysis: for companies with predictable cash flows; revenue or ARR multiples for high-growth tech

But the range is also informed by pre-roadshow investor conversations. Since 2019, SEC Rule 163B has allowed all issuers (not just emerging growth companies) to conduct "testing the waters" meetings with qualified institutional buyers before the S-1 is even filed publicly. These conversations give underwriters a read on where institutional demand is likely to materialise before the company is exposed to public scrutiny.

The SEC's range rules

SEC Securities Offering Reform rules impose a hard constraint on the preliminary range: it must be no more than $2 wide if the maximum price is $10 or less, or 20% of the maximum price if above $10. If the final offering price falls outside this range, the issuer must file a new registration statement or post-effective amendment. This is not a technicality. A deal that prices significantly above or below the filed range creates disclosure obligations and can delay the offering.

One common misconception to correct

Several widely-read sources state that the SEC "approves" the registration statement before pricing. This is wrong. The SEC declares the registration statement effective. It does not approve the accuracy or merits of the offering. The distinction matters: effectiveness means the SEC has completed its review and raised no further comments, not that it has endorsed the company or its valuation.


Phase 2: Bookbuilding, the Actual Demand Discovery

Bookbuilding is the process by which the lead underwriter solicits non-binding indications of interest from institutional investors during the roadshow, aggregates them into a demand curve, and uses that curve to set the final price. It is not marketing. It is price discovery.

What the "book" actually contains

Each IOI specifies:

  • The number of shares the investor wants
  • Sometimes a maximum price the investor is willing to pay
  • The investor's identity and account type (long-only fund, hedge fund, etc.)

The underwriter plots these IOIs against price to build a demand schedule. At any given price, the book shows how many shares are "covered" (total IOIs relative to shares offered). A book that is 10x covered at the midpoint of the range is a very different negotiating position from one that is 2x covered.

Why allocation discretion matters

Share allocation in a bookbuilt IPO is entirely at the underwriter's discretion. There is no legal requirement to allocate pro rata or by price. Underwriters typically favour long-only institutional investors (mutual funds, pension funds) over hedge funds, and reward investors who provide firm, high-conviction orders rather than "flippers" who intend to sell on day one.

This discretion is the source of the most significant conflict of interest in the entire IPO process. Underwriters have a structural incentive to underprice the deal: a lower price means the stock pops on day one, which rewards the institutional investors the underwriter wants to keep happy for future business. The issuer bears the entire cost of that pop.

Loughran and Ritter's landmark 2002 research documented this precisely. Their explanation: issuers focus on the wealth gain from the IPO rather than the wealth lost to underpricing, making them insufficiently resistant to low pricing. US IPO underpricing averaged approximately 18.8% in the 1990s and spiked to around 65% during the dot-com peak. By 2024, the average first-day return had fallen to approximately 12%, down from 30%+ during the 2020-2021 boom, suggesting underwriters are pricing more accurately in the current environment, according to EY's Global IPO Trends 2025 report.

Key takeaway: A 12% first-day pop on a $500 million IPO represents $60 million transferred from the issuer to institutional investors. That is the cost of systematic underpricing, and it is not accidental.

The 7% solution

The gross underwriting spread for US IPOs under approximately $250 million has been remarkably stable at 7% of gross proceeds, a phenomenon documented in academic literature as the "7% solution." FINRA Rule 5110 subjects total underwriter compensation to FINRA review for fairness, but the 7% norm has persisted despite that scrutiny. Combined with J.P. Morgan's estimate that total IPO costs average 10.5% of gross proceeds (including legal, accounting, and other fees), the pricing decision is only one of several expensive choices an issuer makes.


Phase 3: The Pricing Meeting

The pricing meeting is held the evening before the first day of trading. It is the single moment when the final offering price is agreed, and it is a negotiation, not a formality.

Who is in the room

Typically present:

  • The issuer's CEO, CFO, and general counsel
  • The lead underwriter's deal team and syndicate desk
  • Outside counsel for both sides
  • Sometimes the board chair or a lead independent director

What the underwriter presents

The underwriter presents the final state of the book: total demand at various price points, the quality of the investor base (long-only vs. hedge fund ratio), geographic distribution, and any large anchor orders. They will recommend a price, typically framed as the level at which the book is comfortably oversubscribed.

What the issuer can push back on

The issuer can and should push back if:

  • The recommended price is materially below the midpoint of the filed range without a clear demand-side explanation
  • The book is heavily covered at prices above the recommendation
  • The investor mix is skewed toward short-term holders

In practice, issuers rarely push back hard. Loughran and Ritter's prospect theory explanation holds: the excitement of completing the IPO makes the "money on the table" feel abstract. Finance teams that have done the valuation work and understand the demand curve are better positioned to negotiate.

The Rule 424(b) filing

Once the price is agreed, the final prospectus must be filed with the SEC on a Rule 424(b) prospectus supplement within two business days. This filing discloses the final offering price, the underwriting discount, and the net proceeds to the company, as required by Regulation S-K Item 501.


Phase 4: Greenshoe and Post-Pricing Stabilisation

The greenshoe option (formally the overallotment option) allows underwriters to sell up to 15% more shares than originally planned, and it functions as the primary price stabilisation mechanism in US IPOs. Most explanations stop at "extra shares." The actual mechanic is more interesting.

How the greenshoe actually works

At pricing, the underwriter sells 115% of the planned offering (the base shares plus the 15% overallotment). This creates a short position in the underwriter's account.

  • If the stock rises after the IPO: The underwriter exercises the greenshoe option, buying the extra 15% from the issuer at the offering price. The short position is covered, the issuer raises slightly more capital, and the underwriter earns the spread.
  • If the stock falls after the IPO: The underwriter buys shares in the open market at below the offering price to cover the short, supporting the stock price. Those shares are returned, not purchased from the issuer. The underwriter profits from the difference between the offering price and the lower market price.

This mechanic provides a genuine price floor for approximately 30 days post-IPO. It is not charity. The underwriter profits either way. But the stabilisation effect is real and is the main reason newly-listed stocks rarely fall sharply in the first month.

Regulation M constraints

Regulation M (SEC Rules 101-105) is the primary anti-manipulation rule governing the pricing period. Key provisions:

  • Rule 101 restricts underwriters and selling shareholders from bidding for or purchasing the security being distributed during the "restricted period," typically one or five business days before pricing.
  • Rule 104 permits stabilising bids at or below the offering price, but these must be disclosed.
  • Rule 105 prohibits short selling the offered security within five business days before pricing and then purchasing in the IPO.

Compliance officers should note that Reg M violations are an active enforcement area. The quiet period rules that govern what the issuer can say are covered separately in IPO Quiet Period Rules: The 2026 Compliance Reference.


How Direct Listing Pricing Works Differently

In a direct listing, there is no bookbuilding and no price range set in advance. The opening price is determined by an exchange auction on the first day of trading.

The SEC's 2020 approval of NYSE's direct listing with capital raise rules was a landmark: direct listings can now raise primary capital, directly competing with traditional IPOs. Nasdaq followed with equivalent rules.

FeatureTraditional Bookbuilt IPODirect Listing
Price discovery mechanismBookbuilding (IOIs from institutions)Exchange opening auction
Price certainty before day 1Yes (agreed at pricing meeting)No (reference price is non-binding)
New capital raisedYes (primary shares sold)Yes (since 2020 SEC rule change)
Underwriter price supportYes (greenshoe, stabilisation)No
Underwriting spread~7% of gross proceedsNone (financial advisor fee only)
Lock-up periodTypically 90-180 daysTypically none
Best suited forCompanies needing capital, broad distributionWell-known brands with existing investor demand

The reference price set by the financial advisor in a direct listing is purely indicative. The actual opening price is whatever the exchange auction clears at. This eliminates the bookbuilding discount but also removes the price certainty and aftermarket support that underwriters provide. Spotify (2018) and Coinbase (2021) used direct listings successfully. Neither needed to raise primary capital at the time of listing, which simplified the mechanics considerably.

For a full comparison of going-public paths including SPAC mechanics, see Direct Listing vs IPO vs SPAC 2026: The Decision Framework.


The Dutch Auction Alternative

A Dutch auction IPO lets investors submit bids specifying quantity and maximum price. The clearing price is set where supply equals demand, and all successful bidders pay that same price.

Google's 2004 IPO is the most studied example. Google filed its S-1/A with an initial range of $108-$135 per share. A Playboy interview published during the quiet period triggered a prospectus amendment requirement, and the deal ultimately priced at $85, raising approximately $1.67 billion. The auction was widely seen as only partially successful at reducing underpricing: the stock still closed its first day well above $100.

The Dutch auction has not become mainstream for two reasons. First, it requires investors to commit to a price before seeing the full book, which most institutional investors resist. Second, the absence of underwriter allocation discretion removes the relationship incentive that keeps large institutional investors engaged in the process. Without that engagement, demand signals are weaker and price discovery is less reliable.


Practical Constraints CFOs Must Plan Around

The 135-day financial statement rule

Regulation S-X Rule 3-12 requires that audited financial statements in the S-1 be no older than 135 days at the time of effectiveness. This creates a hard deadline constraint on IPO timing. If the SEC review process runs longer than expected (the initial review takes approximately 30 days, with additional rounds for comment responses, per PwC's 2024 IPO Guide), the company may need to update its financial statements, potentially delaying the pricing date by weeks.

The lock-up expiry pricing event

The IPO pricing decision has a downstream consequence that most articles ignore. The lock-up period, typically 90 to 180 days post-IPO, prevents insiders and pre-IPO shareholders from selling shares immediately. Academic research documents average negative abnormal returns of 1-3% around lock-up expiry dates as the market anticipates increased supply. The structure of the original allocation, specifically who received shares and at what price, directly affects how much selling pressure materialises at expiry. CFOs should model this when deciding on the size of the offering and the composition of the investor base.

For a detailed treatment of lock-up mechanics and waiver risk, see IPO Lock-Up Agreement: 2026 Practitioner Walkthrough.

The 2026 market context

The 2025-2026 IPO market has been characterised by selective reopening after the 2022-2023 drought. Renaissance Capital's 2025 US IPO Annual Review notes that high-quality, profitable companies with clear growth stories have priced successfully, while speculative or unprofitable issuers face significant pricing resistance. Underwriters have responded by tightening price ranges and being more conservative in initial range-setting to avoid busted IPOs. The SEC's 2024 final SPAC rules, effective July 2024, effectively closed the SPAC pricing arbitrage by imposing new disclosure and liability requirements on de-SPAC transactions, pushing more companies back toward the traditional bookbuilt process.

Global IPO volumes in 2024 reached 1,215 deals raising $121.2 billion, a 7% increase in deal count but a 5% decrease in proceeds versus 2023, according to EY's Global IPO Trends 2025. The average first-day return of approximately 12% in 2024 suggests the market is pricing more accurately than during the 2020-2021 peak, but systematic underpricing has not disappeared.


How to Evaluate Your Underwriter's Pricing Recommendation

This is the question most CFO guides never answer. Here is a practical framework:

  1. Demand the full book, not a summary. Ask to see the demand schedule at each price point, the investor-by-investor breakdown, and the long-only vs. hedge fund split. You are entitled to this information. If the underwriter is reluctant to share it, that is itself a signal.

  2. Compare the recommendation to your own valuation work. Your Deloitte IPO readiness process should have produced a credible financial model. If the underwriter's recommended price implies a multiple materially below your comparable company analysis, ask for the specific demand-side evidence that justifies the discount.

  3. Check the coverage ratio at the recommended price. A book that is 8x covered at the midpoint and 4x covered at the top of the range is a different situation from a book that is 2x covered at the midpoint. The former supports pricing at or above the midpoint. The latter does not.

  4. Scrutinise the investor mix. A book dominated by hedge funds and momentum traders will produce a volatile aftermarket. A book anchored by long-only institutions with multi-year holding horizons supports price stability. Push for the latter.

  5. Understand the greenshoe economics. If the underwriter recommends pricing at the bottom of the range and the stock pops 20% on day one, the underwriter exercises the greenshoe and profits from the spread. The issuer gets nothing from that pop. Make sure the pricing recommendation reflects your interests, not just the underwriter's.

  6. Know your walk-away point. Agree internally, before the pricing meeting, on the minimum price below which you would postpone the offering. A busted IPO is bad. A withdrawn IPO is recoverable. Pricing too low and watching the stock pop 30% while your employees' options are diluted is the worst outcome.


FAQ

Do IPO prices usually fall after the offering? Not immediately, largely because of the greenshoe stabilisation mechanism. Over the medium term, academic research shows that IPOs underperform the market over a 3-5 year horizon on average, though outcomes vary widely by sector and vintage year. The first-day pop is the most reliable pattern: averaging approximately 12% in 2024.

What is the difference between the IPO price and the opening price? The IPO price (or offering price) is the price agreed at the pricing meeting and at which shares are sold to institutional investors in the primary offering. The opening price is the first traded price on the exchange, set by the market auction on day one. The gap between the two is the "first-day pop" and represents the underpricing cost to the issuer.

What did Warren Buffett say about IPOs? Buffett has consistently been sceptical of IPOs as investments, noting that the seller (the company and its insiders) chooses when to sell, which is rarely when the price is low. He has said he cannot recall buying an IPO in his 60-plus years of investing. This is a useful framing for issuers too: the pricing process is designed to serve the underwriter's institutional clients, not the issuer.

What are the four main steps of the IPO pricing process? Pre-roadshow price range calibration (including testing-the-waters meetings under Rule 163B), bookbuilding during the roadshow (10-14 days of IOI aggregation), the pricing meeting (the evening before trading), and post-pricing stabilisation via the greenshoe option and Reg M-compliant market support.

What is a busted IPO? A busted IPO is one where the stock trades below the offering price in the aftermarket. It signals that the deal was overpriced, damages management credibility with institutional investors, and can impair the company's ability to raise follow-on capital. Underwriters use the greenshoe short-covering mechanic to prevent this for approximately 30 days, but if fundamental demand is absent, stabilisation has limits.

How does ESG disclosure affect IPO pricing? Increasingly, institutional investors factor ESG quality into their IOIs. Companies with credible, ISSB or CSRD-aligned sustainability disclosures in their S-1 face less pricing resistance from ESG-mandated funds, which now represent a significant share of the institutional investor base. Weak or absent ESG disclosure can narrow the investor universe and compress the demand curve at higher price points, directly affecting where the book covers.

Run your financial reporting on Finrep